Search

everythinglearnresearchcommunity

for

Search:↓

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Hair loss in women linked to higher sexual dysfunction risk.

77% of recovered COVID-19 patients in Nepal experienced long-term symptoms like fatigue, hair loss, and breathing issues.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

AB+ blood group is more common in alopecia areata patients.

Gray hair can potentially be reversed, leading to new treatments.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

People with obstructive sleep apnea are more likely to get herpes zoster, but nightmares don't affect the risk.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Nanoemulgel improves delivery and effectiveness of plant-based drugs for various conditions.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.